Voyager Therapeutics, Inc. (VYGR) Net income 2016–2025
Voyager Therapeutics, Inc. (VYGR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$119.7MFY2025 · since FY2016: -$40.2M → -$119.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$119.7M | -84.2% |
| FY2024 | -$65.0M | -149.1% |
| FY2023 | $132.3M | +385.1% |
| FY2022 | -$46.4M | +34.8% |
| FY2021 | -$71.2M | -293.8% |
| FY2020 | $36.7M | +184.3% |
| FY2019 | -$43.6M | +50.6% |
| FY2018 | -$88.3M | -24.9% |
| FY2017 | -$70.7M | -75.9% |
| FY2016 | -$40.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice